| Challenges of Heterotopic Ossification‐molecular background and current treatment strategies P Łęgosz, K Drela, Ł Pulik, S Sarzyńska, P Małdyk Clinical and Experimental Pharmacology and Physiology, 2018 | 61 | 2018 |
| Modified frailty index as a predictor of the long-term functional result in patients undergoing primary total hip arthroplasty Ł Pulik, K Jaśkiewicz, S Sarzyńska, P Małdyk, P Łęgosz Reumatologia/Rheumatology 58 (4), 213-220, 2020 | 25 | 2020 |
| The survey of cells responsible for heterotopic ossification development in skeletal muscles—human and mouse models Ł Pulik, B Mierzejewski, MA Ciemerych, E Brzóska, P Łęgosz Cells 9 (6), 1324, 2020 | 24 | 2020 |
| An update on joint-specific outcome measures in total hip replacement Ł Pulik, K Romaniuk, K Jaśkiewicz, P Wojtyński, P Łęgosz, P Małdyk Reumatologia/Rheumatology 58 (2), 107-115, 2020 | 17 | 2020 |
| Efficacy and safety of nucleoside‐sparing regimen based on raltegravir and ritonavir‐boosted darunavir in HIV‐1‐infected treatment‐experienced patients E Jabłonowska, P Pulik, A Kalinowska, J Gąsiorowski, M Parczewski, ... Journal of Medical Virology 89 (12), 2122-2129, 2017 | 14 | 2017 |
| Matrix metalloproteinases in rheumatoid arthritis and osteoarthritis: a state of the art review Ł Pulik, P Łęgosz, G Motyl Reumatologia 61 (3), 191, 2023 | 11 | 2023 |
| Impact of multiple factors on the incidence of developmental dysplasia of the hip: risk assessment tool Ł Pulik, K Płoszka, K Romaniuk, A Sibilska, A Jedynak, I Tołwiński, ... Medicina 58 (9), 1158, 2022 | 9 | 2022 |
| The update on scales and questionnaires used to assess cervical spine disorders Ł Pulik, N Dyrek, A Piwowarczyk, K Jaśkiewicz, S Sarzyńska, P Łęgosz Physical Therapy Reviews 26 (2), 150-158, 2021 | 9 | 2021 |
| Heterotopic ossification and clinical results after total hip arthroplasty using the anterior minimally invasive and anterolateral approaches P Łęgosz, S Sarzyńska, Ł Pulik, P Stępiński, P Niewczas, A Kotela, ... Archives of Medical Science 14 (1), 2020 | 8 | 2020 |
| The role of miRNA and lncRNA in heterotopic ossification pathogenesis Ł Pulik, B Mierzejewski, A Sibilska, I Grabowska, MA Ciemerych, ... Stem Cell Research & Therapy 13 (1), 523, 2022 | 7 | 2022 |
| The complexity of molecular processes in osteoarthritis of the knee joint P Łęgosz, S Sarzyńska, Ł Pulik, D Kotrych, P Małdyk Open Medicine 15 (1), 366-375, 2020 | 6 | 2020 |
| Increased serum levels of progranulin (PGRN) in patients with haemophilic arthropathy A Kotela, P Wojdasiewicz, P Łęgosz, S Sarzyńska, K Drela, Ł Pulik, ... Clinical and Experimental Pharmacology and Physiology 46 (4), 373-379, 2019 | 6 | 2019 |
| The use of type I collagen cross-linked C-telopeptide (CTX-1) as a biomarker associated with the formation of periprosthetic ossifications following total hip joint arthroplasty P Łęgosz, Ł Pulik, P Stępiński, J Janowicz, A Wirkowska, A Kotela, ... Annals of Clinical & Laboratory Science 48 (2), 183-190, 2018 | 6 | 2018 |
| The Update on Instruments Used for Evaluation of Comorbidities in Total Hip Arthroplasty Łukasz Pulik, Michał Podgajny, Wiktor Kaczyński, Sylwia Sarzyńska, Paweł Łęgosz Indian Journal of Orthopaedics, 2021 | 4 | 2021 |
| Dual therapy based on raltegravir and boosted protease inhibitors–the experience of Polish centers E Jabłonowska, P Pulik, A Kalinowska, J Gąsiorowski, M Parczewski, ... Archives of Medical Science 14 (4), 860-864, 2018 | 4 | 2018 |
| Screening of Developmental Dysplasia of the Hip in Europe: A Systematic Review W Krysta, P Dudek, Ł Pulik, P Łęgosz Children 11 (1), 97, 2024 | 3 | 2024 |
| The use of mixed reality in custom-made revision hip arthroplasty: a first case report P Łęgosz, K Starszak, M Stanuch, M Otworowski, Ł Pulik, ... JoVE (Journal of Visualized Experiments), e63654, 2022 | 3 | 2022 |
| Żylna choroba zakrzepowo-zatorowa–zasady terapii z punktu widzenia lekarzy zabiegowców P Łęgosz, S Sarzyńska, Ł Pulik, P Małdyk Z praktyki ortopedy 5, 0 | 2 | |
| Żylna choroba zakrzepowo-zatorowa w ortopedii. Case repor P Łęgosz, S Sarzyńska, P Małdyk, Ł Pulik Z praktyki ortopedy, 0 | 2 | |
| Zastosowanie siarczanu chondroityny w leczeniu choroby zwyrodnieniowej stawów i prawidłowej funkcji chrząstki stawowej P Łęgosz, S Sarzyńska, P Małdyk, Ł Pulik Praktyczna Ortopedia i Traumatologia 17, 2020 | 1 | 2020 |
